Pharma investment in UK rises as government increases drug pricing and engagement

The UK trade group says pharmaceutical investment is picking up after a lull last year.

The uptick follows recent government steps to raise reimbursement rates for medicines and to foster closer collaboration with drug makers.

Analysts view the trend as a sign that policy changes are making the UK a more attractive market for pharma companies, potentially boosting R&D and manufacturing activity.